• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3
1
1
1

COUNTRY

1

CATEGORIES

  • 7
  • 7
  • 2
  • 1
  • 1

PRICE

1
1
14
17

PUBLISHED

1
3
13
17

PRODUCT TYPE

16
1

Search "Momenta Pharmaceuticals Inc-Therapeutic Competitors" returned 17 results.

PRODUCT TITLE

The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

“The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways” provides insights on the biosimilars market revenues and growth until 2015 Further, the distribution...

December 2009
FROM
Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review

Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review Summary Watson Pharmaceuticals, Inc. (Watson Pharmaceuticals) is a specialty pharmaceutical company. It carries out...

April 2012
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

Metastatic Pancreatic Cancer - Pipeline Review, H1 2015 Summary This, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic...

January 2015
FROM

Pemphigus - Pipeline Review, H2 2014

Pemphigus - Pipeline Review, H2 2014 Summary This, ‘Pemphigus - Pipeline Review, H2 2014’, provides an overview of the Pemphigus’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH,...

September 2013
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H2 2014

Metastatic Pancreatic Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Pancreatic Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic...

July 2014
FROM

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2014

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2014 Summary This, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review,...

October 2014
FROM

Encephalomyelitis - Pipeline Review, H2 2014

Encephalomyelitis - Pipeline Review, H2 2014 Summary This, ‘Encephalomyelitis - Pipeline Review, H2 2014’, provides an overview of the Encephalomyelitis’s therapeutic pipeline. This report provides...

November 2014
FROM

Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Inflammation - Pipeline Review, H1 2014’, provides an overview of the Inflammation’s therapeutic pipeline. This report provides...

June 2014
FROM

Arthritis - Pipeline Review, H2 2014

Arthritis - Pipeline Review, H2 2014 Summary This, ‘Arthritis - Pipeline Review, H2 2014’, provides an overview of the Arthritis’s therapeutic pipeline. This report provides comprehensive information...

July 2014
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H1 2014

Metastatic Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Pancreatic...

February 2014
FROM

Breast Cancer - Pipeline Review, H2 2014

Breast Cancer - Pipeline Review, H2 2014 Summary This, ‘Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)

This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used...

September 2013
FROM

Metastatic Melanoma - Pipeline Review, H2 2014

Metastatic Melanoma - Pipeline Review, H2 2014 Summary This, ‘Metastatic Melanoma - Pipeline Review, H2 2014’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. This report...

September 2014
FROM

Breast Cancer - Pipeline Review, H1 2014

Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report...

March 2014
FROM

Metastatic Melanoma - Pipeline Review, H1 2014

Metastatic Melanoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2014’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. This...

March 2014
FROM
Global Biosimilars Industry 2015 Global Biosimilars Industry 2015 - Product Thumbnail Image

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

February 2015
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG